191
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Progress of Pretreatment and Analytical Methods of Proton Pump Inhibitors: An Update since 2010

, ORCID Icon, , ORCID Icon &

References

  • Rosenshein, B.; Flockhart, D. A.; Ho, H. Induction of Testosterone Metabolism by Esomeprazole in a CYP2C19*2 Heterozygote. Am. J. Med. Sci. 2004, 327, 289–293. DOI: 10.1097/00000441-200405000-00032..
  • Song, W.; Dong, L.; Zhou, Y.; Fu, Y.; Xu, W. Catalytic Asymmetric Synthesis of Esomeprazole by a Titanium Complex with a Hexa-Aza-Triphenolic Macrocycle Ligand. Synth. Commun. 2015, 45, 70–77. DOI: 10.1080/00397911.2014.952307.
  • Mehul, S. D. B.; Patel, M.; Patel, H. D.; Mori, K. N. An Overview of the Recent Developments in Analytical Methodologies for Determination of Proton Pump Inhibitors in Bulk Drugs, Pharmaceuticals and Biological Matrices. Eurasian J. Anal. Chem. 2014, 9, 25–48. *
  • Patel, M. M.; Bhuva, S. D.; Patel, M. M. Proton Pump Inhibitors: recent Developments in Analytical Methodologies. Rev. Anal. Chem. 2015, 34, 29–43. DOI: 10.1515/revac-2014-0019.
  • Kosma, C. I.; Lambropoulou, D. A.; Albanis, T. A. Analysis, Occurrence, Fate and Risks of Proton Pump Inhibitors, Their Metabolites and Transformation Products in Aquatic Environment: A Review. Sci. Total Environ. 2016, 569-570, 732–750. DOI: 10.1016/j.scitotenv.2016.06.160.
  • Joshi, A. A.; Nerkar, P. P. Determination of Proton Pump Inhibitors by Spectrophotometric, Chromatographic and by Hyphenated Techniques. Crit. Rev. Anal. Chem. 2021, 51, 527–548. DOI: 10.1080/10408347.2020.1750339.
  • Elkady, E. F.; Fouad, M. A.; Jaadan, B. M. LC-MS/MS Bioassay of Four Proton Pump Inhibitors. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2018, 1076, 61–69. DOI: 10.1016/j.jchromb.2018.01.022.
  • A. E.; Zaher, E. E.; Kady, H. M.; El Messiry, H. E.; El Ghwas, O. M.; E.; Houssini. Synchronous LC-MS/MS Determination of Pantoprazole and Amitriptyline in Rabbit Plasma: Application to Comparative in Vivo Pharmacokinetic Study of Novel Formulated Effervescent Granules with Its Marketed Tablet Dosage Form. Heliyon 2021, 7, e07752. DOI: 10.1016/j.heliyon.2021.e07752.
  • Dotsikas, Y.; Apostolou, C.; Soumelas, S.; Kolocouri, F.; Ziaka, A.; Kousoulos, C.; Loukas, Y. L. Validation of a Novel, Fully Automated High Throughput High-Performance Liquid Chromatographic/Tandem Mass Spectrometric Method for Quantification of Pantoprazole in Human Plasma. J. AOAC Int. 2010, 93, 1129–1136. DOI: 10.1093/jaoac/93.4.1129.
  • Luo, L.; Wen, X.; Du, Y.; Jiang, Z.; Guo, X. Enantioselective Analysis of Lansoprazole in Rat Plasma by LC-MS/MS: Application to a Stereoselective Pharmacokinetic Study. Biomed. Chromatogr. 2018, 32, e4345. DOI: 10.1002/bmc.4345.
  • Emami, J.; Rezazadeh, M.; Kalani, M. Quantification of Pantoprazole by High Performance Liquid Chromatography (HPLC) Method: In Vitro and in Vivo Applications. J. Liquid Chromatogr. Related Technol. 2014, 37, 681–695. DOI: 10.1080/10826076.2012.758137.
  • Li, S.; Jiang, H.; Wang, Y.; Liu, Y.; Shen, X.; Liang, W.; Hong, Z. High-Throughput Chiral LC-MS/MS Method Using Overlapping Injection Mode for the Determination of Pantoprazole Enantiomers in Human Plasma with Application to Pharmacokinetic Study. Chirality 2016, 28, 569–575. DOI: 10.1002/chir.22616.
  • Yang, Y.; Li, X.; Zhou, Q.; Sun, L.; Zhang, T. Simultaneous Determination of Naproxen and Esomeprazole in Beagle Dog Plasma by Supercritical Fluid Chromatography-Tandem Mass Spectrometry Coupled with Evaporation-Free Liquid-Liquid Extraction. J. Pharm. Biomed. Anal. 2021, 193, 113668. DOI: 10.1016/j.jpba.2020.113668.
  • Wang, Z.; Sun, W.; Lin, Z. F.; Sun, R.; Huang, C. K.; Ye, W. J.; Dong, Y. Y.; Zhang, X. D.; Chen, R. J. A UHPLC-MS/MS Method Coupled with Liquid-Liquid Extraction for the Quantitation of Phenacetin, Omeprazole, Metoprolol, Midazolam and Their Metabolites in Rat Plasma and Its Application to the Study of Four CYP450 Activities. J. Pharm. Biomed. Anal. 2019, 163, 204–210. DOI: 10.1016/j.jpba.2018.10.012.
  • Hotha, K. K.; Bharathi, D. V.; Jagadeesh, B.; Ravindranath, L. K.; Jaya Veera, K. N.; Venkateswarulu, V. Development and Validation of a Highly Sensitive LC-MS/MS Method for Quantitation of Dexlansoprazole in Human Plasma: Application to a Human Pharmacokinetic Study. Biomed. Chromatogr. 2012, 26, 192–198. DOI: 10.1002/bmc.1645.
  • Sekharan, C. B.; Rao, M. P.; Mahesh, M.; Chandramouli, I.; Seemanth, J. Determination of the Dexlansoprazole in Bulk and Spiked Human Plasma by Extraction Spectrophotometry. Int. Lett. Chem. Phys. Astron. 2015, 52, 28–38. DOI: 10.18052/www.scipress.com/ILCPA.52.28.
  • Ganesh, M.; BhagiyaLakshmi, M.; Hemalatha, P.; Patil, R.; Sakthimanigandan, K.; Jang, H. T.; Rajasekar, K. Liquid Chromatography–Electrospray Tandem Mass Spectrometry (Lc-Ms/Ms) Determination of Lansoprazole in Human Plasma. J. Liquid Chromatogr. Related Technol. 2011, 34, 129–142. DOI: 10.1080/10826076.2011.540915.
  • Bhattacharya, S.; Sarkar, P.; Khanam, J.; Pal, T. K. Simultaneous Determination of Paclitaxel and Lansoprazole in Rat Plasma by LC-MS/MS Method and Its Application to a Preclinical Pharmacokinetic Study of Investigational PTX-LAN-PLGA Nanoformulation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2019, 1124, 331–339. DOI: 10.1016/j.jchromb.2019.06.031.
  • Dixit, S.; Dubey, R.; Bhushan, R. Normal and Polar-Organic-Phase High-Performance Liquid Chromatographic Enantioresolution of Omeprazole, Rabeprazole, Lansoprazole and Pantoprazole Using Monochloro-Methylated Cellulose-Based Chiral Stationary Phase and Determination of Dexrabeprazole. Biomed. Chromatogr. 2014, 28, 112–119. DOI: 10.1002/bmc.2915.
  • Tan, Z-r.; Wang, Y-c.; Chen, Y.; Guo, D.; Cao, S.; Zhang, W.; Zhou, G.; Zhou, H-h.; Ouyang, D-s Development and Validation of a LC–MS/MS Method for the Determination of Ilaprazole Enantiomers and Its Application to a Bioequivalence Study in Healthy Chinese Volunteers. Chromatographia 2012, 75, 95–101. DOI: 10.1007/s10337-011-2178-0.
  • Chen, M.; Xia, Y.; Ma, Z.; Li, L.; Zhong, D.; Chen, X. Validation of a Chiral Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Pantoprazole in Dog Plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 906, 85–90. DOI: 10.1016/j.jchromb.2012.08.019.
  • Chunduri, R. H. B.; Dannana, G. S. Development and Validation of a High Throughput UPLC-MS/MS Method for Simultaneous Quantification of Esomeprazole, Rabeprazole and Levosulpiride in Human Plasma. J. Pharm. Anal. 2016, 6, 190–198. DOI: 10.1016/j.jpha.2016.01.001.
  • Oh, K. S.; Park, S. J.; Shinde, D. D.; Shin, J. G.; Kim, D. H. High-Sensitivity Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Determination of Five Drugs and Their Cytochrome P450-Specific Probe Metabolites in Human Plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 895-896, 56–64. DOI: 10.1016/j.jchromb.2012.03.014.
  • Pedersen-Bjergaard, S.; Rasmussen, K. E. Liquid-Phase Microextraction and Capillary Electrophoresis of Acidic Drugs. Electrophoresis 2000, 21, 579–585. DOI: 10.1002/(SICI)1522-2683(20000201)21:3 < 579::AID-ELPS579 > 3.0.CO;2-E.
  • Horta, R. P.; do Amaral, B.; Peralta-Zamora, P. G.; Silva, B. J. G. Evaluation of a Hollow-Fiber Liquid-Phase Microextraction Technique for the Simultaneous Determination of PPI Drugs in Human Plasma by LC-DAD. J. Chromatogr. Sci. 2018, 56, 564–573. DOI: 10.1093/chromsci/bmy023.
  • Zhao, P.; Deng, M.; Huang, P.; Yu, J.; Guo, X.; Zhao, L. Solid-Phase Extraction Combined with Dispersive Liquid-Liquid Microextraction and Chiral Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Enantioselective Determination of Representative Proton-Pump Inhibitors in Water Samples. Anal. Bioanal. Chem. 2016, 408, 6381–6392. DOI: 10.1007/s00216-016-9753-z.
  • Cai, Q.; Zhao, T.; Zhang, L.; Zhao, P.; Zhu, Y.; Xu, H.; Hou, X. A New Strategy for Extraction and Depuration of Pantoprazole in Rat Plasma: Vortex Assisted Dispersive Micro-Solid-Phase Extraction Employing Metal Organic Framework MIL-101(Cr) as Sorbent Followed by Dispersive Liquid-Liquid Microextraction Based on Solidification of a Floating Organic Droplet. J. Pharm. Biomed. Anal. 2019, 172, 86–93. DOI: 10.1016/j.jpba.2019.04.016.
  • Iqbal, M.; Ezzeldin, E.; Haq, N.; Alam, P. An Ultraperformance Liquid Chromatography Tandem-Mass Spectrometry Method for Determination of Multiclass Pharmaceuticals in Water Sample by Dispersive Liquid-Liquid Microextraction Combined with Ultrasound Assisted Reverse Extraction from Solidified Floating Organic Droplets. ACS Omega 2021, 6, 7524–7532. DOI: 10.1021/acsomega.0c06047.
  • Wojnicz, A.; Gil García, A. I.; Román-Martínez, M.; Ochoa-Mazarro, D.; Abad-Santos, F.; Ruiz-Nuño, A. Improvement and Validation of a High-Performance Liquid Chromatography in Tandem Mass Spectrometry Method for Monitoring of Omeprazole in Plasma. Ther. Drug Monit. 2015, 37, 381–388. DOI: 10.1097/FTD.0000000000000155.
  • Zendelovska, D.; Atanasovska, E.; Gjorgjievska, K.; Pavlovska, K.; Jakjovski, K.; Zafirov, D.; Trojacanec, J. A New Solid-Phase Extraction Method for Determination of Pantoprazole in Human Plasma Using High-Performance Liquid Chromatography. Open Access Maced. J. Med. Sci. 2019, 7, 1757–1761. DOI: 10.3889/oamjms.2019.237.
  • Nevado, J. J.; Penalvo, G. C.; Dorado, R. M.; Robledo, V. R. Simultaneous Determination of Omeprazole and Their Main Metabolites in Human Urine Samples by Capillary Electrophoresis Using Electrospray Ionization-Mass Spectrometry Detection. J. Pharm. Biomed. Anal. 2014, 92, 211–219. DOI: 10.1016/j.jpba.2013.12.020.
  • Bhaskara, B. L.; Anil Kumar, U. R.; Basavaiah, K. Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for the Determination of Pantoprazole Sodium in Human Urine. Arabian J. Chem. 2011, 4, 163–168. DOI: 10.1016/j.arabjc.2010.06.033.
  • Gopinath, S.; Kumar, R. S.; Shankar, M. B.; Danabal, P. Development and Validation of a Sensitive and High-Throughput LC-MS/MS Method for the Simultaneous Determination of Esomeprazole and Naproxen in Human Plasma. Biomed. Chromatogr. 2013, 27, 894–899. DOI: 10.1002/bmc.2878.
  • Camacho-Munoz, D.; Kasprzyk-Hordern, B.; Thomas, K. V. Enantioselective Simultaneous Analysis of Selected Pharmaceuticals in Environmental Samples by Ultrahigh Performance Supercritical Fluid Based Chromatography Tandem Mass Spectrometry. Anal. Chim. Acta 2016, 934, 239–251. DOI: 10.1016/j.aca.2016.05.051.
  • Boix, C.; Ibanez, M.; Bagnati, R.; Zuccato, E.; Sancho, J. V.; Hernandez, F.; Castiglioni, S. High Resolution Mass Spectrometry to Investigate Omeprazole and Venlafaxine Metabolites in Wastewater. J. Hazard Mater. 2016, 302, 332–340. DOI: 10.1016/j.jhazmat.2015.09.059.
  • Costin, M.; Cioroiu, B.; Agoroaei, L.; Butnaru, E. Contribution to the Development and Validation of a High Performance Liquid Chromatography by the UV Detection Method for Isoniazid and Omeprazole Determination. Cellulose Chem. Technol. 2012, 46, 511–516.
  • Dewani, A. P.; Tripathi, A. S.; Shelke, P. G.; Bakal, R. L.; Mohale, D. S.; Chandewar, A. V. Development of Solid-Phase Extraction and HPLC Method for Simultaneous Estimation of Ilaprazole and Glimepiride in Rat Plasma. J. Chromatogr. Sci. 2017, 55, 327–333. DOI: 10.1093/chromsci/bmw189.
  • Zohdi, Z.; Hashemi, M.; Uheida, A.; Moein, M. M.; Abdel-Rehim, M. Graphene Oxide Tablets for Sample Preparation of Drugs in Biological Fluids: Determination of Omeprazole in Human Saliva for Liquid Chromatography Tandem Mass Spectrometry. Molecules 2019, 24, 1191. DOI: 10.3390/molecules24071191.
  • Ahmed, H.; Wahbi, A. A.; Elmongy, H.; Amini, A.; Koyi, H.; Branden, E.; Abdel-Rehim, M. Determination and Pharmacokinetics of Omeprazole Enantiomers in Human Plasma and Oral Fluid Utilizing Microextraction by Packed Sorbent and Liquid Chromatography-Tandem Mass Spectrometry. Int. J. Anal. Chem. 2021, (2021) 8845139. DOI: 10.1155/2021/8845139.
  • Ali, I.; Rani, D.; Al-Othman, Z. A. Analysis of Ibuprofen, Pantoprazole, and Itopride Combination Therapeutic Drugs in Human Plasma by Solid Phase Membrane Microtip Extraction and High-Performance Liquid Chromatography Methods Using New Generation Core Shell C18 Column. J..Liquid Chromatogr. Related Technol. 2016, 39, 339–345. DOI: 10.1080/10826076.2016.1152583.
  • Sayyahmanesh, M.; Naghian, E.; Sahebi, H.; Asgari, S. Preconcentration and Determination of Pantoprazole by Solid-Phase Extraction Coupled with Spectrophotometry Using Iron Oxide Nanoparticles Modified with Cetyltrimethylammonium Bromide. Nano BioMed. Eng. 2015, 7, 102–110. DOI: 10.5101/nbe.v7i3.p102-110.
  • Varela-Martínez, D. A.; González-Sálamo, J.; González-Curbelo, M. Á.; Hernández-Borges, J. Chapter 14 - Quick, Easy, Cheap, Effective, Rugged, and Safe (QuEChERS) Extraction. In Liquid-Phase Extraction; Colin F. Poole, Ed.; Elsevier, 2020, pp 399–437. DOI: 10.1016/B978-0-12-816911-7.00014-1.
  • Lun, J.; Ma, S.; Xue, M.; Zhao, P.; Song, Y.; Guo, X. Simultaneous Enantiomeric Analysis of Five Proton-Pump Inhibitors in Soil and Sediment Using a Modified QuEChERS Method and Chiral High Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry. Microchem. J. 2021, 160, 105625. DOI: 10.1016/j.microc.2020.105625.
  • Balkrishna, M. V.; Surekha, B.; Waghmare, K.; Kulkarni, A. S. * Method Development and Validation for the Simultaneous Determination of Omeprazole in Sold Dosage Form by RP-HPLC. Int. J. Res. Pharmaceut. Sci. 2011, 2, 404–408.
  • Atulita Mullapudi, A. M.; Sirisha Pingali, S. P.; Tata Santosh, T. S. Development and Validation of a Stability Indicating Method for the Simultaneous Determination of Levosulpiride and Rabeprazole by High Performance Liquid Chromatography. Int. J. Pharmaceut. Drug Anal. 2013, 1, 25–36.
  • Rao, P. V.; Kumar, M. N.; Kumar, M. R.; Novel, A. Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and Its Impurities in Bulk Drug and Pharmaceutical Dosage Forms. Sci. Pharm. 2013, 81, 183–193. DOI: 10.3797/scipharm.1210-09.
  • De Smet, J.; Boussery, K.; De Cock, P.; De Paepe, P.; Remon, J. P.; Van Winckel, M.; Van Bocxlaer, J. A Bio-Analytical Hydrophilic Interaction LC-MS/MS Method for the Simultaneous Quantification of Omeprazole and Lansoprazole in Human Plasma in Support of a Pharmacokinetic Omeprazole Study in Children. J. Sep. Sci. 2010, 33, 939–947. DOI: 10.1002/jssc.200900590.
  • Borges, K. B.; Durán-Patrón, R.; Sánchez, A. J. M.; Pupo, M. T.; Bonato, P. S.; Collado, I. G. Fast HPLC Analysis of Omeprazole, 5-Hydroxyomeprazole and Omeprazole Sulfone in Liquid Culture Medium Using a Monolithic Column for Application in Biotransformation Studies with Fungi. J. Braz. Chem. Soc. 2011, 22, 1140–1149. DOI: 10.1590/S0103-50532011000600020.
  • Ribeiro, A. R.; Maia, A. S.; Cass, Q. B.; Tiritan, M. E. Enantioseparation of Chiral Pharmaceuticals in Biomedical and Environmental Analyses by Liquid Chromatography: An Overview. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2014, 968, 8–21. DOI: 10.1016/j.jchromb.2014.02.049.
  • Sun, L. N.; Zhang, Y.; Yang, Y. Q.; Shen, Y.; Ying, Y. W.; Su, Y. W.; Zhang, X. H.; Liu, Y.; Huang, X.; Wang, Y. Q. Simultaneous Enantioselective Determination of Omeprazole, Rabeprazole, Lansoprazole, and Pantoprazole Enantiomers in Human Plasma by Chiral Liquid Chromatography-Tandem Mass Spectrometry. J. Sep. Sci. 2020, 43, 3183–3196. DOI: 10.1002/jssc.202000226.
  • Barreiro, J. C.; Vanzolini, K. L.; Cass, Q. B. Direct Injection of Native Aqueous Matrices by Achiral-Chiral Chromatography Ion Trap Mass Spectrometry for Simultaneous Quantification of Pantoprazole and Lansoprazole Enantiomers Fractions. J. Chromatogr. A 2011, 1218, 2865–2870. DOI: 10.1016/j.chroma.2011.02.064.
  • Challa, B. R.; Boddu, S. H.; Awen, B. Z.; Chandu, B. R.; Bannoth, C. K.; Khagga, M.; Kanala, K.; Shaik, R. P. Development and Validation of a Sensitive Bioanalytical Method for the Quantitative Estimation of Pantoprazole in Human Plasma Samples by LC-MS/MS: application to Bioequivalence Study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878, 1499–1505. DOI: 10.1016/j.jchromb.2010.03.049.
  • Brown, S. D.; Connor, J. D.; Smallwood, N. C.; Lugo, R. A. Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry. Int. J. Anal. Chem. 2011, (2011, ) 832414. DOI: 10.1155/2011/832414.
  • Eliuk, S.; Makarov, A. Evolution of Orbitrap Mass Spectrometry Instrumentation. Annu. Rev. Anal. Chem. (Palo Alto Calif.) 2015, 8, 61–80. DOI: 10.1146/annurev-anchem-071114-040325.
  • Rossi, A.; Castrati, L.; Colombo, P.; Flammini, L.; Barocelli, E.; Bettini, R.; Elviri, L. Development and Validation of a DESI-HRMS/MS Method for the Fast Profiling of Esomeprazole and Its Metabolites in Rat Plasma: A Pharmacokinetic Study. Drug Test Anal. 2016, 8, 208–213. DOI: 10.1002/dta.1805.
  • Nagavi, J. Bio-Analytical UFLC Method Development and Validation for Simultaneous Estimation of Clopidogrel and Pantoprazole in Human Plasma. Int. J. Pharm. Sci. Rev. Res. 2014, 27, 157–162.
  • Ibrahim, F.; Wahba, M. E. Liquid Chromatography Coupled with Fluorimetric Detection and Third Derivative Synchronous Fluorescence Spectroscopy as Two Analytical Methods for the Simultaneous Determination of Rabeprazole Sodium and Domperidone after Derivatization with 4-Chloro-7-Nitrobenzofurazan. J. Fluoresc. 2014, 24, 1137–1147. DOI: 10.1007/s10895-014-1394-z.
  • Su, C.; Yang, H.; Meng, X.; Fawcett, J. P.; Cao, J.; Yang, Y.; Gu, J. Determination of Rabeprazole Enantiomers in Dog Plasma by Supercritical Fluid Chromatography Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study. J. Sep. Sci. 2017, 40, 1010–1016. DOI: 10.1002/jssc.201601232.
  • Hancu, G.; Papp, L. A.; Rusu, A. Chiral Separation of the Enantiomers of Omeprazole and Pantoprazole by Capillary Electrophoresis. Chromatographia 2015, 78, 279–284. DOI: 10.1007/s10337-014-2827-1.
  • Guan, J.; Li, H.; Yan, F.; Shi, S.; Wang, S. Optimization and Validation of a Novel CE Method for the Enantioseparation of Pantoprazole and Related Benzimididazole Using a Dual Chiral Selector System. Electrophoresis 2014, 35, 2800–2806. DOI: 10.1002/elps.201400305.
  • Papp, L. A.; Hancu, G.; Gyéresi, Á.; Kelemen, H.; Szabó, Z. I.; Noszál, B.; Dubský, P.; Tóth, G. Chiral Separation of Lansoprazole and Rabeprazole by Capillary Electrophoresis Using Dual Cyclodextrin Systems. Electrophoresis 2019, 40, 2799–2805. DOI: 10.1002/elps.201900107.
  • Sui, X.; Guan, J.; Li, X.; Gu, L.; Yan, F.; Shi, S.; Zhang, D. Preparation of a Polydopamine/Beta-Cyclodextrin Coated Open Tubular Capillary Electrochromatography Column and Application for Enantioseparation of Five Proton Pump Inhibitors. J. Sep. Sci. 2021, 44, 3295–3304. DOI: 10.1002/jssc.202100298.
  • Fan, S.; Guan, J.; Yan, F.; Zhang, D.; Shi, S.; Wang, S. Preparation of Open-Tubular CEC Column Bonded with 6-O-Monotosyl-Deoxy-β-Cyclodextrin and Its Application in the Enantioseparation of Several Related Benzimidazoles. Sep. Sci. Plus 2020, 3, 255– 261. DOI: 10.1002/sscp.202000014.
  • Gu, L.; Guan, J.; Huang, Z.; Huo, H.; Shi, S.; Zhang, D.; Yan, F. β-Cyclodextrin Covalent Organic Framework Supported by Polydopamine as Stationary Phases for Electrochromatographic Enantioseparation. Electrophoresis 2022, 43, 1446–1454. DOI: 10.1002/elps.202200029.
  • Gupta, P.; Goyal, R. N. A Sensitive Pyrolytic Graphite Sensor for Determination of Omeprazole in Human Blood Plasma and Pharmaceuticals. J. Electrochem. Soc. 2014, 161, H255–H259. DOI: 10.1149/2.093404jes.
  • Jain, R.; Tiwari, D. C.; Shrivastava, S. A Sensitive Voltammetric Sensor Based on Synergistic Effect of Polyaniline and Zirconia Nanocomposite Film for Quantification of Proton Pump Inhibitor Esomeprazole. J. Electrochem. Soc. 2014, 161, B39–B44. DOI: 10.1149/2.018404jes.
  • Khalili, Z.; Nezhadali, A. Nanomolar Detection of Lansoprazole: computational–Assisted to Monomer–Templet Complex Study Based on Molecularly Imprinted Polymer and Electrochemical Determination. Chem. Pap. 2022, 76, 1185–1198. DOI: 10.1007/s11696-021-01933-z.
  • Shahin, M. Application of Tlc Densitometric Method for Simultaneous Determination of Aspirin and Omeprazole in Pharmaceutical Preparation, Innoriginal. Int. J. Sci. 2018, 5, 47–50.
  • Abo-Gharam, A. H.; El-Kafrawy, D. S.; Abdel-Khalek, M. M.; Mahrous, M. S.; Belal, T. S. Spectrophotometric and Chromatographic Methods for Simultaneous Determination of Aspirin and Omeprazole. Anal. Chem. Lett. 2020, 10, 240–262. DOI: 10.1080/22297928.2020.1768893.
  • Pankaj, K.; Chandni, C. Quantitative Simultaneous Estimation of Aspirin and Omeprazole by RP-HPLC Method Implementing AQbD Approach in Pharmaceutical Dosage Form. Int. J. Pharm. Sci. Res. 2019, 10, 3777–3784. DOI: 10.13040/IJPSR.0975-8232.10(8).3777-84.
  • Balkrishna, M. V.; Surekha, B.; Waghmare, K.; Kulkarni, A. S. Method Development and Validation for the Simultaneous Determination of Omeprazole in Sold Dosage Form by RP-HPLC. Int. J. Res. Pharm. Sci. 2011, 2, 404–408.
  • Shaikh, Z.; Ahad, A.; Patel, S.; Farooqui, M. Development & Validation of HPLC Method for Simultaneous Estimation of Drotaverine & Omeprazole. IJCTR 2020, 13, 1–10. DOI: 10.20902/IJCTR.2019.130101.
  • Yenduri, G.; Navaluri, S. Analytical High Performance Liquid Chromatography Method for Estimating the Combination of Aspirin and Omeprazole in Bulk and Tablet Dosage Form. JRP 2018, 22, 172–180. DOI: 10.12991/jrp.2018.91.
  • Vani, R. Analytical Method Development and Validation for the Determination of Omeprazole and Aspirin Using Reverse Phase HPLC Method in Bulk and Dosage Form. UJPR 2017, 2, 25–29. DOI: 10.22270/ujpr.v2i4.R6.
  • Mishra, P. K.; Upadhyay, S.; Tripathi, A. C.; Saraf, S. K. Stability Indicating HPLC-UV Method for Simultaneous Estimation of Pantoprazole, Domperidone and Drotaverine. Int. J. PharmTech Res. 2015, 8, 912–923.
  • Gurupadayya, B. M.; Sama, S. Bio-Analytical Determination of Clopidogrel and Pantoprazole by RP-HPLC Method in Rat Plasma: Application to Drug Interaction Study. Asian J. Pharm. Clin. Res. 2014, 7, 10–13.
  • Lal, B.; Jaimini, M.; Kapoor, D. U. Development and Validation of a RP-HPLC Method for the Simultaneous Estimation of Clarithromycin, Tinidazole and Lansoprazole in Fixed Dose Combinations. Tropical J. Pharmaceut. Life Sci. 2021, 8, 01–10.
  • Agarwal, D.; Goyal, R.; Dadhich, B. Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Lansoprazole, Clarithromycin and Tinidazole in Combined Dosage Form. Asian J. Pharmaceut. Res. Dev. 2021, 9, 102–109. DOI: 10.22270/ajprd.v9i1.872.
  • Reddy, B. P. K.; Reddy, Y. R.; Ramachandran, D. Determination of Pantoprazole Sodium and Lansoprazole in Individual Tablet Dosage Forms by RP-HPLC Using Single Mobile Phase. E-J. Chem. 2009, 6, 489–494. DOI: 10.1155/2009/502472.
  • Yamuna, G. Method Development and Validation for Rabeprazole and Domperidone in Combine Dosage Form by RP-HPLC. Int. J. Res. Publicat. Rev. 2020, 1, 147–154.
  • Kim, M.; Yu, S. K.; Truong, Q. K.; Mai, X. L.; Chung, H. K.; Kang, J. S.; Kim, K. H. Determination of Rabeprazole Enantiomers in Commercial Tablets Using Immobilized Cellulose-Based Stationary Phase. Arch. Pharm. Res. 2017, 40, 373–381. DOI: 10.1007/s12272-017-0896-z
  • Rashid, M. A.; Aktar, F.; Uddin, M. G.; Rahman, A.; Sultan, M. Z.; Kayesh, R. Development and Validation of a RP-HPLC Method for the Quantification of Omeprazole in Pharmaceutical Dosage Form. J. Sci. Res. 2013, 5, 335–342. DOI: 10.3329/jsr.v5i2.12779.
  • Flor, S.; Tripodi, V.; Scioscia, S.; Revello, L.; Lucangioli, S. Fast and Sensitive New Hplc-Uv Method for Determination of Omeprazole and Major Related Substances in Pharmaceutical Formulation. J. Liquid Chromatogr. Related Technol. 2010, 33, 1666–1678. DOI: 10.1080/10826076.2010.519232.
  • Aktas, A. H.; Saridag, A. M. Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. J. Chromatogr. Sci. 2017, 55, 798–804. DOI: 10.1093/chromsci/bmx039.
  • Ali, O. T.; Hassan, W. S.; Khayyat, A. N.; Almalki, A. J.; Sebaiy, M. M. HPLC Determination of Imidazoles with Variant anti-Infective Activity in Their Dosage Forms and Human Plasma. Molecules 2020, 26, 129. DOI: 10.3390/molecules26010129.
  • Nassar, M. W. I.; Attia, K. A. M.; Mohamed, A. A.; Shahin, M. HPLC Method for the Simultaneous Estimation of Aspirin and Omeprazole in Their New Combination. Analytical Chem. Lett. 2017, 7, 438–444. DOI: 10.1080/22297928.2017.1326841.
  • Letica, J.; Marković, S.; Zirojević, J.; Nikolić, K.; Agbaba, D. High-Performance Liquid Chromatographic Determination of Pantoprazole and Its Main Impurities in Pharmaceuticals. J. AOAC Int. 2010, 93, 1121–1128. DOI: 10.1093/jaoac/93.4.1121.
  • Samnani, P.; Kumar, K. Development and Validation of a New HPLC Method for Simultaneous Determination of Esomeprazole, Venlafaxine HCl and Fenofibrate. Int. J. ChemTech Res. 2014, 6, 838–844.
  • Nataraj, K. S.; Duza, M. B.; Pragallapati, K.; Kumar, D. K. Development and Validation of RP-HPLC Method for the Estimation of Omeprazole in Bulk and Capsule Dosage Forms. Int. Curr. Pharm. J. 2012, 1, 366–369. DOI: 10.3329/icpj.v1i11.12062.
  • Borges, K. B.; Snchez, A. J. M.; Pupo, M. T.; Bonato, P. S.; Collado, I. G. Ultra-Fast Gradient LC Method for Omeprazole Analysis Using a Monolithic Column: assay Development, Validation, and Application to the Quality Control of Omeprazole Enteric-Coated Pellets. J. AOAC Int. 2010, 93, 1811–1820. DOI: 10.1093/jaoac/93.6.1811.
  • Afzal, M.; Muddassir, M.; Alarifi, A.; Ansari, M. T. Box-Behnken Assisted Validation and Optimization of an RP-HPLC Method for Simultaneous Determination of Domperidone and Lansoprazole. Separations 2021, 8, 5. DOI: 10.3390/separations8010005.
  • Nalini, M.; Haribabu, B. Stability Indicating Rp-Hplc Method for Determination of Omeprazole and Cinitapride in Combined Pharmaceutical Dosage Form. Rasayan J. Chem. 2015, 8, 433–442.
  • Noubarani, M.; Keyhanfar, F.; Motevalian, M.; Mahmoudian, M. Improved HPLC Method for Determination of Four PPIs, Omeprazole, Pantoprazole, Lansoprazole and Rabeprazole in Human Plasma. J. Pharm. Pharm. Sci. 2010, 13, 1–10. DOI: 10.18433/j3gp4q.
  • Housheh, S.; Bachour, G.; Chehna, M. F. Development of Rapid and Simple Analytical Method for Some Proton Pump Inhibitors (PPIs) Using HPLC. Jordan Journal of Pharmaceutical Sciences 2011, 4, 222–236.
  • Meher, M.; Bhangale, C.; Dholas, R.; Prashant, V.; Pawar, R. Analytical Method Development, Validation and Forced Degradation Studies of Lansoprazole by RP-HPLC. Asian J. Pharm. Res. Dev. 2018, 6, 21–29. DOI: 10.22270/ajprd.v6.i4.387.
  • Baraka, M.; Elsadek, M.; Abdelaziz, L.; Elbermawi, S. RP-HPLC Method for the Simultaneous Determination of Omeprazole, Tinidazole and Doxycycline Mixture in the Presence of Omeprazole and Tinidazole Degradation Products. Int. J. Curr. Pharmaceut. Res. 2014, 6, 48–53.
  • Ashour, S.; Omar, S. A Modified High-Performance Liquid Chromatographic Method for the Analysis of Pantoprazole Sodium in Pharmaceutical Dosage Forms Using Lansoprazole as Internal Standard. Arabian J. Chem. 2016, 9, S114–S119. S119. DOI: 10.1016/j.arabjc.2011.02.010.
  • Khan, M.; Zuthi, S.; Kayser, M.; Islam, M.; Asad, S.; Rashid, M. A Simple RP-HPLC Method Development and Validation for the Simultaneous Estimation of Naproxen and Rabeprazole. J. App. Pharm. Sci. 2016, 6, 147–152. DOI: 10.7324/JAPS.2016.601123.
  • Bratty, M. A.; Manoharan, G. Development and Validation by RP-HPLC Method for the Simultaneous Quantification of Diclofenac and Rabeprazole, in Capsule Formulation. Indian J. Sci. Technol. 2016, 9, 19. DOI: 10.17485/ijst/2016/v9i19/89023.
  • Ramasamy, M. High-Performance Liquid Chromatography Method for the Quantification of Pantoprazole in Rat Plasma. Int. J. ChemTech. Res. 2010, 2, 885–894.
  • Dadhich, M. B.; Agarwal, D.; Goyal, M. R. Simultaneous Determination Tinidazole, Clarithromycin and Lansoprazole of in Tablets by HPLC. Int. J. All Res. Writ. 2020, 2, 9–14.
  • Gülfen, M.; Canbaz, Y.; Özdemir, A. Simultaneous Determination of Amoxicillin, Lansoprazole, and Levofloxacin in Pharmaceuticals by HPLC with UV–Vis Detector. J. Anal. Test 2020, 4, 45–53. DOI: 10.1007/s41664-020-00121-4.
  • Ranjha, N.; Rashid, Z.; Razzaq, R.; Raza, H.; Hanif, M.; Mahmood, D. Development and Validation of Fast Reversed-Phase HPLC Method for Analysis of Esomeprazole in Rabbit Plasma. Acta Pol. Pharmaceut. Drug Res. 2017, 74, 385–391.
  • Rahic, O.; Vranic, E.; Mujezin, I.; Hadžiabdić, J.; Elezovic, A. Development and Validation of HPLC Method for Determination of Pantoprazole in Pantoprazole Pellets. Int. J. (Toronto, Ont.) 2013, 4, 793–796.
  • Ahmad, L.; Iqbal, Z.; Nazir, S.; Shah, Y.; Khan, A.; Khan, M. I.; Nasir, F.; Khan, A. Optimization and Validation of Hplc-Uv Method for Simultaneous Determination of Omeprazole and Its Metabolites in Human Plasma: Effects of Various Experimental Conditions and Parameters. J. Liquid Chromatogr. Related Technol. 2011, 34, 1488–1501. DOI: 10.1080/10826076.2011.569807.
  • Salomi, P.; Purushothaman, M.; Satyanarayana, S. A New Simple and Sensitive Method for Simultaneous Estimation of Aspirin and Omeprazol in Rat Plasma by RP-HPLC and Its Application to Pharmacokinetic Study. J. Drug Deliv. Therapeut. 2019, 9, 332–338. DOI: 10.22270/jddt.v9i3.2673.
  • Das, P.; Shukla, A.; Maity, A. RP-HPLC Methodology for the Assay of Omeprazole in Omeprazole Buffered Capsule. J. Pharm. Adv. Res. 2020, 3, 988–993.
  • P. S.; Sm, R. B.; A.; Patnaik, S.; Ch, K. Y. Simultaneous Estimation of Rabeprazole and Domperidone in Dosage Forms by RP-HPLC. Int. J. Res. Pharm. Sci. 2014, 5, 259–261.
  • Sindhu, P.; Vijayakumar, D. G.; Sura, R. S. Development and Validated Stability Indicating Rp-Hplc Method for the Determination of Pantoprazole in Pure Form and Its Tablet Dosage Form. World J. Pharm. Res. 2015, 4, 2315–2326.
  • Hussein, R.; Binhashim, N.; Alvi, S.; Hammami, M. A. Validated Reversed Phase Hplc Assay for the Determination of Omeprazole in Human Plasma. Eur. J. Pharmaceut. Med. Res. 2016, 3, 26–30.
  • Bonagani, N.; Rammohan, M.; Nikitha, V.; Prashanth, G.; Santhosh, N.; Reddy, D. P. A Validated Rp HPLC Method for Aspirin and Omeprazole in Its Pure and Capsule Dosage Form. Int. J. Pharmaceut. Biol. Chem. Sci. 2018, 6, 1–14.
  • Jadhav, P. B.; Sarode, T. K. Rp-HPLC Method Development and Validation for Simultaneous Estimation of Aspirin and Omeprazole in Bulk and Dosage Form. J. Drug Deliv. Therapeut. 2018, 8, 322–328. DOI: 10.22270/jddt.v8i5.182.5.
  • Darwish, K. M.; Salama, I.; Mostafa, S.; El-Sadek, M. RP-HPLC/Pre-Column Derivatization for Analysis of Omeprazole, Tinidazole, Doxycycline and Clarithromycin. J. Chromatogr. Sci. 2013, 51, 566–576. DOI: 10.1093/chromsci/bms167.
  • Batthula, S.; Yandamuri, N.; Divya, P.; Narla, L.; Bandam, P.; Allada, S. N. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Lansoprazole and Paliperidone Palmitate in Bulk Drugs. PHARMANEST 2015, 6, 2704–2708.
  • Perumal, S. S.; Ekambaram, S. P.; Raja, S. Analytical Method Development and Validation of Simultaneous Estimation of Rabeprazole, Pantoprazole, and Itopride by Reverse-Phase High-Performance Liquid Chromatography. J. Food Drug Anal. 2014, 22, 520–526. DOI: 10.1016/j.jfda.2014.05.003.
  • Ahmed, K. Simultaneous Determination of Omeprazole, Tinidazole and Clarithromycin in Bulk Powder and Helicure Tablets by HPLC. J. Chromat. Sep. Techniq. 2014, 05, 1–5. DOI: 10.4172/2157-7064.1000221.
  • Kamal, A. H.; Marie, A. A.; Hammad, S. F. Stability Indicating RP-HPLC Method for Simultaneous Determination of Omeprazole and Aspirin in the Presence of Salicylic Acid as Degradation Product. Microchem. J. 2020, 152, 104350. DOI: 10.1016/j.microc.2019.104350.
  • Vidyadhara, S.; Rao, Y. S.; Ramu, A.; Sasidhar, R. L.; Ramya, A. J. Method Development and Validation for the Simultaneous Estimation of Cinitapride and Pantoprazole in Solid Dosage Forms by RP-HPLC. Orientjchem 2013, 29, 1213–1220. DOI: 10.13005/ojc/290355.
  • Karra, U.; Yarkala, S. A Simple and Validated Reverse Phase HPLC Methodfor the Determination of Rabeprazole inPharmaceutical Dosage Forms. J. Chem. 2010, 7, 569–577. DOI: 10.1155/2010/412194.
  • Kumar, V.; Kumar, S.; Padhy, G. New Rp-Hplc Method for the Simultaneous Determination of Omeprazole and Aspirin in Bulk and Tablet Dosage Form. Res. J. Pharm. Life Sci. 2020, 1, 42–50.
  • Maslarska, V.; Bozhanov, S.; Tsvetkova, B.; Peikova, L. High Pressure Liquid Chromatographic Method for Simultaneous Determination of Ketoprofen and Omeprazole. Pharmacia 2018, 65, 3–8.
  • Dhaneshwar, S. R.; Jagtap, V. N. Development and Validation of Stability Indicating RP-HPLC-PDA Method for Tenatoprazole and Its Application for Formulation Analysis and Dissolution Study. AJAC 2011, 02, 126–134. DOI: 10.4236/ajac.2011.22014.
  • Wang, S.; Zhang, D.; Wang, Y.; Liu, X.; Liu, Y.; Xu, L. Gradient High Performance Liquid Chromatography Method for Simultaneous Determination of Ilaprazole and Its Related Impurities in Commercial Tablets. Asian J. Pharm. Sci. 2015, 10, 146–151. DOI: 10.1016/j.ajps.2014.09.001.
  • Mavani, D. RP-HPLC Method Development and Validation for Simultaneous Estimation of Ilaprazole and Domperidone in Their Combined Dosage Form. J. Drug Deliv. Therapeut. 2022, 4, 43–48. DOI: 10.22270/jddt.v4i4.912.
  • Tamboli, R.; Chauhan, V.; Pathan, M.; Tirgar, S.; Shah, D.; Parmar, R. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Ilaprazole and Domperidone in Pharmaceutical Dosage Form. PharmaTutor 2014, 2, 149–156.
  • Tandel1, J. N.; Dilipkumar, P.; Chauhan, P.; Shah, S. K. An Isocratic RP-HPLC Method for Simultaneous Analysis of Ilaprazole and Domperidone in Pharmaceutical Formulation. Asian J. Pharmaceut. Res. 2018, 8, 1–5. DOI: 10.5958/2231-5691.2018.00001.1.
  • Patel, G.; Prajapati, K. M.; Prajapati, B.; Shah, S. K. Simultaneous Estimation of Ilaprazole and Domperidone in Pharmaceutical Dosage Form. Int. J. Pharmaceut. Sci. Nanotechnol. (IJPSN) 2016, 9, 3549–3555. DOI: 10.37285/ijpsn.2016.9.6.6.
  • Satheesh, B.; Sree Ganesh, K. K.; Saravanan, D.; Ramakant, K. G.; Sivananthan, S. Simultaneous Determination of Ilaprazole and Its Related Compounds in Pharmaceutical Dosage Forms by Uplc. J. Liquid Chromatogr. Related Technol. 2013, 36, 2968–2981. DOI: 10.1080/10826076.2012.733995.
  • Addo, R. T.; Davis, K.; Ubale, R.; Owen, J. S.; Watkins, E. B. Development and Validation of a UPLC Method for Rapid and Simultaneous Analysis of Proton Pump Inhibitors. AAPS PharmSciTech 2015, 16, 30–34. DOI: 10.1208/s12249-014-0207-7.
  • Kučerová, K.; Reiská, V.; Švec, F.; Krčmová, L. K.; Matysová, L. Fast Determination of Omeprazole in Extemporaneous Suspensions Used in Paediatrics and Stability Studies. Anal. Methods 2019, 11, 517–523. DOI: 10.1039/C8AY02547A.
  • Nagavi, J. B.; Gurupadayya, B.; Sirisha, T.; Gopalakrishna, R. N. Bio-Analytical UFLC Method Development and Validation for Simultaneous Estimation of Clopidogrel and Pantoprazole in Human Plasma. Int. J. Pharmaceut. Sci. Rev. Res. 2014, 27, 157–162.
  • Brinda, M. N.; Reddy, D. V. K.; Goud, E. S. Development and Validation of Ultra Performance Liquid Chromatographic Method for Assay of Omeprazole Blend. Int. J. Pharm. Biol. Sci. 2014, 4, 38–44.
  • Srinivas, P.; Rao, T. S.; Ramakrishnan, E.; Gowda, D. V. Development and Validation of Analytical Method for the Estimation of Omeprazole, Domperidone and Their Related Substances. Int. J. Pharma Bio Sci. 2013, 4, 906–911.
  • Panda, S. S.; Ravi Kumar Bera, V. V.; Beg, S.; Mandal, O. Analytical Quality by Design (AQbD)-Oriented RP-UFLC Method for Quantification of Lansoprazole with Superior Method Robustness. J. Liquid Chromatogr. Related Technol. 2017, 40, 479–485. DOI: 10.1080/10826076.2017.1327442.
  • Singh, S.; Choudhary, N.; Rai, J.; Siddiqui, I.; Sharma, S. A Validated RP-UPLC Method Development for Simultaneous Estimation of Lansoprazole and Naproxen in Bulk and Tablet Dosage Form. Asian J. Pharm. Clin. Res. 2013, 6, 150–152.
  • Abdel-Gawad, S. A.; Arab, H. H.; Alabbas, A. B. Validated Simultaneous Gradient Ultra-Performance Liquid Chromatographic Quantification of Some Proton Pump Inhibitor Drug Residues in Saudi Pharmaceutical Industrial Wastewater. Molecules 2021, 26, 4358. DOI: 10.3390/molecules26144358.
  • Thummala, V. R.; Seshadri, R. K.; Tharlapu, S. S.; Ivaturi, M. R.; Nittala, S. R. Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules. Sci. Pharm. 2014, 82, 307–326. DOI: 10.3797/scipharm.1310-17.
  • Simpemba, E.; Liu, R.; Sun, C.; Agbokponto, J. E.; Ding, L. Simultaneous Determination of Rabeprazole and Its Two Active Metabolites in Human Urine by Liquid Chromatography with Tandem Mass Spectrometry and Its Application in a Urinary Excretion Study. J. Sep. Sci. 2014, 37, 1951–1956. DOI: 10.1002/jssc.201400162.
  • Sudha, T.; Reddy, K. K.; Hemalatha, P. V.; Ravikumar, V. R. An Lc- Ms/Ms Method for the Determination of Omeprazole on Proton Pump Inhibitor in Human Plasma. Indonesian J. Pharm 2016, 27, 80–91. DOI: 10.14499/indonesianjpharm27iss2pp80.
  • Vijayaraghavan, R.; Jayababu, G.; Prasad, R.; Thirugnanam, P. E.; Shivkumar, G.; Sriraam, V. T.; Kumar, G. R. Bio-Analytical Method Development and Validation for Omeprazole Using LC-MS/MS. Int. J. Pharm. Sci. Res. 2011, 2, 2475–2481.
  • Kachave, R.; Kale, M.; Wagh, R. Development and Validation of a LC-MS/MS Method to Determine Lansoprazole in Human Plasma. TOACJ 2015, 8, 7–11. DOI: 10.2174/1874065001508010007.
  • Velan, S.; Vuppu, S. A Sensitive Ultra-Fast Bioanalytical Method for the Quantification of Rabeprazole in Human Plasma. J. Appl. Pharmaceut. Sci. 2016, 6, 178–183. DOI: 10.7324/japs.2016.60726.
  • Ahmad, L.; Iqbal, Z.; Shah, Y.; Watson, D. G.; Khan, A.; Khan, M. I.; Khuda, F.; Khan, A.; Nasir, F. Simple and Fast Liquid Chromatography–Mass Spectrometry (LC–MS) Method for the Determination of Omeprazole, 5-Hydroxyomeprazole, and Omeprazole Sulphone in Human Plasma. J. Liquid Chromatogr. Related Technol. 2015, 38, 692–697. DOI: 10.1080/10826076.2014.951763.
  • Zhang, W.; Han, F.; Guo, P.; Zhao, H.; Lin, Z. J.; Huang, M. Q.; Bertelsen, K.; Weng, N. Simultaneous Determination of Tolbutamide, Omeprazole, Midazolam and Dextromethorphan in Human Plasma by LC-MS/MS–A High Throughput Approach to Evaluate Drug-Drug Interactions. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878, 1169–1177. DOI: 10.1016/j.jchromb.2010.03.026.
  • Qiu, X.; Xu, R.; Zheng, Y.; Zhan, H.; Wang, Z.; Hu, L. Determination of Pantoprazole in Rat Plasma by LC–MS/MS and Its Application to Pharmacokinetics. Lat. Am. J. Pharm. 2012, 31, 653–658.
  • Zhou, G.; Tan, Z. R.; Zhang, W.; Ou-Yang, D. S.; Chen, Y.; Guo, D.; Liu, Y. Z.; Fan, L.; Deng, H. W. An Improved LC-MS/MS Method for Quantitative Determination of Ilaprazole and Its Metabolites in Human Plasma and Its Application to a Pharmacokinetic Study. Acta Pharmacol. Sin. 2009, 30, 1330–1336. DOI: 10.1038/aps.2009.120.
  • Khimani, R.; Kapupara, P. Development and Validation of HPLC Method for Determination of Ilaprazole and Levosulpride. Res. J. Pharm. Technol. 2018, 11, 1491. DOI: 10.5958/0974-360X.2018.00277.9.
  • Bora, R.; S.n, M. Development and Validation Using Protein Precipitation Extraction for the Estimation of Dexlansoprazole in Spiked Human Plasma by Liquid Chromatography Tandem Mass Spectrometry. J. Xi’an Petrol. Inst. 2021, 17, 132–141.
  • Sensitive Analytical Liquid Chromatography-Tandem Mass Spectroscopy Method for the Estimation of Dexlansoprazole in Pharmaceutical Formulations. J. Appl. Pharmaceut. Sci. 2018, 8, 33–36. DOI: 10.7324/japs.2018.8706.
  • Ou, F.; Zhou, Y.; Lei, J.; Zeng, S.; Wu, F.; Zhang, N.; Yu, L. Development of a UHPLC-MS/MS Method for the Quantification of Ilaprazole Enantiomers in Rat Plasma and Its Pharmacokinetic Application. J. Pharm. Anal. 2020, 10, 617–623. DOI: 10.1016/j.jpha.2019.09.002.
  • Ma, J.; Wang, S.; Zhang, M.; Zhang, Q.; Zhou, Y.; Lin, C.; Lin, G.; Wang, X. Simultaneous Determination of Bupropion, Metroprolol, Midazolam, Phenacetin, Omeprazole and Tolbutamide in Rat Plasma by UPLC-MS/MS and Its Application to Cytochrome P450 Activity Study in Rats. Biomed. Chromatogr. 2015, 29, 1203–1212. DOI: 10.1002/bmc.3409.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.